OBJECTIVE: We conducted a systematic review to evaluate the characteristics of human papillomavirus testing, particularly Hybrid Capture 2, in follow-up evaluations after treatment for cervical intraepithelial neoplasia for the detection of residual or recurrent cervical intraepithelial neoplasia grade >/= 2. STUDY DESIGN: Medline was searched for relevant studies that were published between 1992 and September 2007. Of the 1107 citations that were identified, 20 articles met the inclusion criteria. RESULTS: Studies that used polymerase chain reaction testing were too heterogeneous to combine. We identified 5 studies that performed both Hybrid Capture 2 and colposcopy. Pooled sensitivity for Hybrid Capture 2 was 90.7% (95% CI, 75.4-96.9%), and pooled specificity was 74.6% (95% CI, 60.4-85.0%). Pooled sensitivity for cervical cytologic testing was 76.6% (95% CI, 62.0-86.8%), and pooled specificity was 89.7% (95% CI, 22.7-99.6%). CONCLUSION: Hybrid Capture 2 testing can identify approximately 91% of women with residual or recurrent cervical intraepithelial neoplasia grade >/= 2; however, approximately 30% of women would undergo colposcopy in follow-up evaluation.
OBJECTIVE: We conducted a systematic review to evaluate the characteristics of human papillomavirus testing, particularly Hybrid Capture 2, in follow-up evaluations after treatment for cervical intraepithelial neoplasia for the detection of residual or recurrent cervical intraepithelial neoplasia grade >/= 2. STUDY DESIGN: Medline was searched for relevant studies that were published between 1992 and September 2007. Of the 1107 citations that were identified, 20 articles met the inclusion criteria. RESULTS: Studies that used polymerase chain reaction testing were too heterogeneous to combine. We identified 5 studies that performed both Hybrid Capture 2 and colposcopy. Pooled sensitivity for Hybrid Capture 2 was 90.7% (95% CI, 75.4-96.9%), and pooled specificity was 74.6% (95% CI, 60.4-85.0%). Pooled sensitivity for cervical cytologic testing was 76.6% (95% CI, 62.0-86.8%), and pooled specificity was 89.7% (95% CI, 22.7-99.6%). CONCLUSION: Hybrid Capture 2 testing can identify approximately 91% of women with residual or recurrent cervical intraepithelial neoplasia grade >/= 2; however, approximately 30% of women would undergo colposcopy in follow-up evaluation.
Authors: E Kucera; G Sliutz; K Czerwenka; G Breitenecker; S Leodolter; A Reinthaller Journal: Eur J Obstet Gynecol Reprod Biol Date: 2001-12-10 Impact factor: 2.435
Authors: Ruud L M Bekkers; Willem J G Melchers; Judith M J E Bakkers; Antonius G J M Hanselaar; Wim G V Quint; Henk Boonstra; Leon F A G Massuger Journal: Int J Cancer Date: 2002-11-10 Impact factor: 7.396
Authors: Kristina Elfgren; Marcel Jacobs; Jan M M Walboomers; Chris J L M Meijer; Joakim Dillner Journal: Obstet Gynecol Date: 2002-11 Impact factor: 7.661
Authors: E Paraskevaidis; G Koliopoulos; Y Alamanos; V Malamou-Mitsi; E D Lolis; H C Kitchener Journal: Obstet Gynecol Date: 2001-11 Impact factor: 7.661
Authors: M A Nobbenhuis; C J Meijer; A J van den Brule; L Rozendaal; F J Voorhorst; E K Risse; R H Verheijen; T J Helmerhorst Journal: Br J Cancer Date: 2001-03-23 Impact factor: 7.640
Authors: Aimée R Kreimer; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Paula González; Robert D Burk; Carolina Porras; Mark E Sherman; Franklin Demuth; Li Cheung; Concepción Bratti; Ana Cecilia Rodríguez Journal: Int J Cancer Date: 2011-08-30 Impact factor: 7.396
Authors: Ryan C V Lintao; Leslie Faye T Cando; Glenmarie Angelica S Perias; Ourlad Alzeus G Tantengco; Ian Kim B Tabios; Clarissa L Velayo; Sheriah Laine M de Paz-Silava Journal: Front Med (Lausanne) Date: 2022-06-20
Authors: Joy Melnikow; Colleen McGahan; George F Sawaya; Thomas Ehlen; Andrew Coldman Journal: J Natl Cancer Inst Date: 2009-05-12 Impact factor: 13.506
Authors: Hormuzd A Katki; Mark Schiffman; Philip E Castle; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Tina Raine-Bennett; Julia C Gage; Walter K Kinney Journal: J Low Genit Tract Dis Date: 2013-04 Impact factor: 1.925
Authors: Suzanne M Garland; Jorma Paavonen; Unnop Jaisamrarn; Paulo Naud; Jorge Salmerón; Song-Nan Chow; Dan Apter; Xavier Castellsagué; Júlio C Teixeira; S Rachel Skinner; James Hedrick; Genara Limson; Tino F Schwarz; Willy A J Poppe; F Xavier Bosch; Newton S de Carvalho; Maria Julieta V Germar; Klaus Peters; M Rowena Del Rosario-Raymundo; Grégory Catteau; Dominique Descamps; Frank Struyf; Matti Lehtinen; Gary Dubin Journal: Int J Cancer Date: 2016-09-09 Impact factor: 7.396